Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.

Repetitive finger tapping is commonly used to assess bradykinesia in Parkinson's disease. The Queen Square Brain Bank diagnostic criterion of Parkinson's disease defines bradykinesia as 'slowness of initiation with progressive reduction in speed and amplitude of repetitive action'. Although progressive supranuclear palsy is considered an atypical parkinsonian syndrome, it is not known whether patients with progressive supranuclear palsy have criteria-defined bradykinesia. This study objectively assessed repetitive finger tap performance and handwriting in patients with Parkinson's disease (n = 15), progressive supranuclear palsy (n = 9) and healthy age- and gender-matched controls (n = 16). The motion of the hand and digits was recorded in 3D during 15-s repetitive index finger-to-thumb tapping trials. The main finding was hypokinesia without decrement in patients with progressive supranuclear palsy, which differed from the finger tap pattern in Parkinson's disease. Average finger separation amplitude in progressive supranuclear palsy was less than half of that in controls and Parkinson's disease (P < 0.001 in both cases). Change in tap amplitude over consecutive taps was computed by linear regression. The average amplitude slope in progressive supranuclear palsy was nearly zero (0.01°/cycle) indicating a lack of decrement, which differed from the negative slope in patients with Parkinson's disease OFF levodopa (-0.20°/cycle, P = 0.002). 'Hypokinesia', defined as <50% of control group's mean amplitude, combined with 'absence of decrement', defined as mean positive amplitude slope, were identified in 87% of finger tap trials in the progressive supranuclear palsy group and only 12% in the Parkinson's disease OFF levodopa group. In progressive supranuclear palsy, the mean amplitude was not correlated with disease duration or other clinimetric scores. In Parkinson's disease, finger tap pattern was compatible with criteria-defined bradykinesia, characterized by slowness with progressive reduction in amplitude and speed and increased variability in speed throughout the tap trial. In Parkinson's disease, smaller amplitude, slower speed and greater speed variability were all associated with a more severe Unified Parkinson's Disease Rating Scale motor score. Analyses of handwriting showed that micrographia, defined as smaller than 50% of the control group's mean script size, was present in 75% of patients with progressive supranuclear palsy and 15% of patients with Parkinson's disease (P = 0.022). Most scripts performed by patients with progressive supranuclear palsy did not exhibit decrements in script size. In conclusion, patients with progressive supranuclear palsy have a specific finger tap pattern of 'hypokinesia without decrement' and they do not have criteria-defined limb bradykinesia. Similarly, 'micrographia' and 'lack of decrement in script size' are also more common in progressive supranuclear palsy than in Parkinson's disease.

[1]  J. Kang,et al.  Micrographia after thalamo-mesencephalic infarction , 1998, Neurology.

[2]  C D Marsden,et al.  The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[3]  N Accornero,et al.  Clinical impairment of sequential finger movements in Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[4]  A. Lees,et al.  Does corticobasal degeneration exist? A clinicopathological re-evaluation. , 2010, Brain : a journal of neurology.

[5]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[6]  R. C. Oldfield The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[7]  A J Lees,et al.  Micrographia associated with a parietal lobe lesion in multiple sclerosis. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[8]  Guido Nolte,et al.  Shared Brain Areas But Not Functional Connections Controlling Movement Timing and Order , 2005, The Journal of Neuroscience.

[9]  A. Berardelli,et al.  Impairment of individual finger movements in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[10]  John C Marshall,et al.  Micrographia in Parkinson’s disease: the effect of providing external cues , 1997, Journal of neurology, neurosurgery, and psychiatry.

[11]  Won Yong Lee,et al.  Micrographia on free writing versus copying tasks in idiopathic Parkinson's disease. , 2005, Parkinsonism & related disorders.

[12]  N. Quinn,et al.  Levodopa challenge test in Parkinson's disease , 1992, The Lancet.

[13]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[14]  M. Hallett,et al.  A mismatch between kinesthetic and visual perception in Parkinson's disease , 1997, Annals of neurology.

[15]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[16]  I Litvan,et al.  The FAB: A frontal assessment battery at bedside , 2000, Neurology.

[17]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[18]  Michael Swash,et al.  LIMB-KINETIC APRAXIA IN PARKINSON DISEASE , 2007, Neurology.

[19]  C. Marsden,et al.  Slowness of movement in Parkinson's disease , 1989, Movement disorders : official journal of the Movement Disorder Society.

[20]  L. Golbe,et al.  A clinical rating scale for progressive supranuclear palsy. , 2007, Brain : a journal of neurology.

[21]  I Litvan,et al.  Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders , 1996, Journal of neuropathology and experimental neurology.

[22]  J. Rothwell,et al.  Parkinsonism following bilateral lesions of the globus pallidus: performance on a variety of motor tasks shows similarities with Parkinson’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  N. Accornero,et al.  Analysis of repetitive and nonrepetitive sequential arm movements in patients with Parkinson's disease , 1994, Movement disorders : official journal of the Movement Disorder Society.

[24]  V. Preedy,et al.  Unified Parkinson's Disease Rating Scale , 2010 .

[25]  G. Halliday,et al.  Substantia nigra pars reticulata neurons in Parkinson's disease. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[26]  J C Rothwell,et al.  Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[27]  Francisco Velasco,et al.  A quantitative evaluation of the effects of L-dopa on Parkinson's disease. , 1973, Neuropharmacology.

[28]  G. Halliday Clinicopathological aspects of motor parkinsonism. , 2007, Parkinsonism & related disorders.

[29]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[30]  D W Dickson,et al.  Atrophy of superior cerebellar peduncle in progressive supranuclear palsy , 2003, Neurology.

[31]  Mark Hallett,et al.  Parkinson revisited: pathophysiology of motor signs. , 2003, Advances in neurology.

[32]  M. Hallett,et al.  Characteristics of the sequence effect in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[33]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 2014, Seminars in Neurology.

[34]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[35]  W. Gibb,et al.  A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's disease , 1988, Neurology.

[36]  M. Delong,et al.  Functional neuroanatomy of the basal ganglia in Parkinson's disease. , 2003, Advances in neurology.

[37]  Andrew J Lees,et al.  Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[38]  M. Hallett,et al.  A functional MRI study of automatic movements in patients with Parkinson's disease. , 2005, Brain : a journal of neurology.

[39]  Marie Vidailhet,et al.  Micrographia secondary to lenticular lesions , 2002, Movement disorders : official journal of the Movement Disorder Society.

[40]  R. Schwab,et al.  Micrographia in Parkinson's disease. , 1972, Journal of the neurological sciences.

[41]  D. Paviour,et al.  Commentary on: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism, by , 2005 .

[42]  M. Bryant,et al.  An investigation of two interventions for micrographia in individuals with Parkinson’s disease , 2010, Clinical rehabilitation.

[43]  Robert Iansek,et al.  The sequence effect and gait festination in Parkinson disease: Contributors to freezing of gait? , 2006, Movement disorders : official journal of the Movement Disorder Society.

[44]  K. Ikeda,et al.  Micrographia in Huntington's disease. , 1999, Journal of the neurological sciences.

[45]  C. Marsden,et al.  Disturbance of sequential movements in patients with Parkinson's disease. , 1987, Brain : a journal of neurology.

[46]  T Lashley,et al.  Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. , 2002, Brain : a journal of neurology.

[47]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[48]  Clifford R Jack,et al.  Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. , 2011, Archives of neurology.

[49]  M. Hallett,et al.  Pathophysiology of bradykinesia in Parkinson's disease. , 2001, Brain : a journal of neurology.

[50]  G. Halliday,et al.  Progressive Supranuclear Palsy Affects both the Substantia Nigra Pars Compacta and Reticulata , 1997, Experimental Neurology.

[51]  A. Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.

[52]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[53]  A. Lees,et al.  Striatonigral degeneration. A clinicopathological study. , 1990, Brain : a journal of neurology.